Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Impact of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, Program Announcement Number PEP 2006-R-07, 18103 [E6-5174]

Download as PDF Federal Register / Vol. 71, No. 68 / Monday, April 10, 2006 / Notices 18103 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers of Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Control of Plague in Uganda, Program Announcement (PA) Number CI 06–007 Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Impact of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, Program Announcement Number PEP 2006–R– 07 [Docket Number NIOSH 068] In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Control of Plague in Uganda, PA Number CI 06–007. Time and Date: 12 p.m.–4 p.m., May 3, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to: Control of Plague in Uganda, Program Announcement Number CI 06–007. For Further Information Contact: Christine Morrison, PhD, Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road, NE, Mailstop D–72, Atlanta, GA 30333, Telephone Number 404–639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5171 Filed 4–7–06; 8:45 am] BILLING CODE 4163–18–P In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control, Special Emphasis Panel (SEP): Impact of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, Program Announcement Number PEP 2006– R–07. Time and Date: 1 p.m.–2 p.m., May 18, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduct expert review of scientific and technical merit of research applications in response to Impact of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, Program Announcement Number PEP 2006–R–07. For Further Information Contact: Felix Rogers, Ph.D., M.P.H., Scientific Review Administrator, CDC, 1600 Clifton Road NE., Mailstop E05, Atlanta, GA 30333, Telephone 404–639–6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5174 Filed 4–7–06; 8:45 am] wwhite on PROD1PC65 with NOTICES BILLING CODE 4163–18–P VerDate Aug<31>2005 19:19 Apr 07, 2006 Jkt 208001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 NIOSH Pilot Study of Truck Driver Anthropometric and Workspace Dimensions; Meeting National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), HHS. ACTION: Notice of public meeting. AGENCY: Name: Consortium Meeting on the NIOSH Pilot Study of Truck Driver Anthropometric and Workspace Dimensions. Meeting Date and Time: April 27, 2006, 8:30 a.m.–4:30 p.m. Place: Room L1CD, NIOSH, CDC, 1095 Willowdale Road, Morgantown, West Virginia. SUMMARY: Purpose: The public meeting will explain and discuss issues related to the current NIOSH pilot project and a possible large-scale research project on U.S. truck driver anthropometric and workspace data. This possible largescale study will establish an anthropometric and workspace database for U.S. truck drivers. The database will be used to formulate anthropometric guidelines, develop digital human models for cab designs, and upgrade current standards for new generation cabs that would accommodate all trucking populations. Updated anthropometric information for cab design will help to increase truck drivers’ visibility, operational comfort, maneuverability, and post-crash survivability, thereby possibly reducing fatal and nonfatal injuries. The current NIOSH pilot study will (1) identify critical cab design criteria and related human body dimensions, (2) establish test procedures for the largescale project, and (3) develop research partnerships with interested parties. The scope of this pilot and possible large-scale study will be limited to medium and heavy trucks and their operators in the continental U.S. Special emphasis will be placed on discussion of the following issues: (1) What are the key anthropometric and workspace dimensions for the design of an ergonomically sound cab? (2) What are the essential adjustment parameters and values of the truck buck that is to be constructed for data collection? (3) What are the essential postures to be scanned in three-dimensional E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 71, Number 68 (Monday, April 10, 2006)]
[Notices]
[Page 18103]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5174]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control, Special 
Emphasis Panel (SEP): Impact of DRG 559 on Costs, Quality and Patient 
Outcomes of Stroke Care, Program Announcement Number PEP 2006-R-07

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control, 
Special Emphasis Panel (SEP): Impact of DRG 559 on Costs, Quality 
and Patient Outcomes of Stroke Care, Program Announcement Number PEP 
2006-R-07.
    Time and Date: 1 p.m.-2 p.m., May 18, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: To conduct expert review of scientific 
and technical merit of research applications in response to Impact 
of DRG 559 on Costs, Quality and Patient Outcomes of Stroke Care, 
Program Announcement Number PEP 2006-R-07.
    For Further Information Contact: Felix Rogers, Ph.D., M.P.H., 
Scientific Review Administrator, CDC, 1600 Clifton Road NE., 
Mailstop E05, Atlanta, GA 30333, Telephone 404-639-6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 4, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-5174 Filed 4-7-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.